Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 361 (9360) , 821-826
- https://doi.org/10.1016/s0140-6736(03)12709-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitisBrain, 2002
- Efficacy of Interferon α-2b and Ribavirin against West Nile Virus In VitroEmerging Infectious Diseases, 2002
- Dengue and Other Emerging FlavivirusesJournal of Infection, 2001
- Emerging arboviral encephalitisBMJ, 2000
- NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: Japanese encephalitisJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Neurological manifestations of dengue infectionThe Lancet, 2000
- New initiatives for the control of Japanese encephalitis by vaccination:Vaccine, 2000
- Poliomyelitis-like illness due to Japanese encephalitis virusThe Lancet, 1998
- Effect of High-Dose Dexamethasone on the Outcome of Acute Encephalitis Due to Japanese Encephalitis VirusThe Journal of Infectious Diseases, 1992
- Levels of Interferon in the Plasma and Cerebrospinal Fluid of Patients with Acute Japanese EncephalitisThe Journal of Infectious Diseases, 1987